The molecular mechanism might be that L-theanine significantly reduced the release of IL-1 and TNF-, and the phosphorylation of NF-B, and increased the ratio of IL-10 to interferon (IFN)-
However, the expression of GPx1 has been reported to be down-regulated in thyroid cancer [44], colorectal cancer [45, 46], and gastric cancer [47], whereas GPx1 has been demonstrated to play an oncogenic role in kidney cancer [48], pancreatic cancer [49], and laryngeal squamous cell carcinoma [50]
The study found that one year after stopping liraglutide (another GLP-1 weight-loss drug), participants who did not exercise regained 6kg of their lost weight
This dual action on both weight and metabolic health makes GLP1 weight loss shots especially valuable for patients with multiple health concerns related to excess weight
Free Radic Biol Med 66:7587